SEQUENT SCIENTIFIC
|
The Current P/E Ratio of SEQUENT SCIENTIFIC is 135.78.
Share Price | ₹175.0 | Aug 07,2025 |
Market Cap | ₹4,380.3 Cr | |
Earnings-TTM | ₹32.3 Cr | TTM-Consolidated Results |
Price/Earnings | 135.78x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SEQUENT SCIENTIFIC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹4,380.3 Cr] as on Aug 07,2025
(/) Earnings [ ₹32.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 135.78x ]
Thus, for SEQUENT SCIENTIFIC , the investors are currently willing to pay 135.78 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SEQUENT SCIENTIFIC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SEQUENT SCIENTIFIC over the last five years.
Historical PE (Price/Earnings) ratio chart of SEQUENT SCIENTIFIC
PE Ratio Performance Analysis for SEQUENT SCIENTIFIC
- SEQUENT SCIENTIFIC 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 58.69x.
- SEQUENT SCIENTIFIC 's operated at median p/e ratio of 62.69x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SEQUENT SCIENTIFIC 's p/e ratio peaked in Mar2025 at 149.64x.
- SEQUENT SCIENTIFIC 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does SEQUENT SCIENTIFIC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SEQUENT SCIENTIFIC | 32.26 | 135.78 | 4,380.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 36.84 | 383,570.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 70.60 | 162,808.0 |
CIPLA LTD | 5,406.81 | 22.28 | 120,468.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.81 | 121,734.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 17.50 | 100,212.0 |
MANKIND PHARMA LTD | 1,905.51 | 55.06 | 104,912.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.61 | 95,124.3 |
LUPIN LTD | 3,722.18 | 23.88 | 88,896.7 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.17 | 62,108.0 |
ABBOTT INDIA LTD | 1,414.44 | 49.22 | 69,623.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SEQUENT SCIENTIFIC 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.50x |
Max industry PE | 135.78x |
Median industry PE | 36.84x |
Average industry PE | 46.43x |
You may also like the below Video Courses